# Safety and Efficacy Assessment of Diagnostic Microprobe (inPROBE) in Women at High Risk of Breast Cancer (Part I Study)

> **NCT05415943** · NA · COMPLETED · sponsor: **SDS Optic S.A.** · enrollment: 18 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Diagnostic microprobe (inPROBE) medical device

## Key facts

- **NCT ID:** NCT05415943
- **Lead sponsor:** SDS Optic S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-24
- **Primary completion:** 2023-03-02
- **Final completion:** 2023-03-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05415943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05415943, "Safety and Efficacy Assessment of Diagnostic Microprobe (inPROBE) in Women at High Risk of Breast Cancer (Part I Study)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05415943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*